Lactobacillus rhamnosus CLR1505 and Reduced Risk of COVID-19 Progression

• Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021?

  • 2021-09-26
  • Review · n = 19
  • Nutrients 13(10)
  • • Viktoria Hawryłkowicz
    • Danuta Lietz-Kijak
    • Karolina Kaźmierczak-Siedlecka
    • Joanna Sołek-Pastuszka
    • Laura Stachowska
    • Marcin Folwarski
    • Miłosz Parczewski
    • Ewa Stachowska

  • PubMed: 34684384
  • DOI: 10.3390/nu13103385

  2 Insights on

  • Reduced Risk of COVID-19 Progression

  • Moderate evidence
  • Rigorous Journal

  Probiotics may support patients by inhibiting the ACE2 receptor, i.e., the passage of the virus into the cell, and may also be effective in suppressing the immune response caused by the proinflammatory cytokine cascade.

  Effect

  Beneficial

  Effect size

  Small